Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

20.93

0.00 (0.00%)

Mar 10, 2026, 4:00 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Surgical & Medical Equipment	8.19M	6.71M	23.54M	4.43M
Surgical & Medical Equipment Growth	21.95%	-71.49%	431.67%	-
Total	8.19M	6.71M	23.54M	4.43M
Total Growth	21.95%	-71.49%	431.67%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
European Union	5.62M	4.66M	20.30M	4.09M
European Union Growth	20.54%	-77.04%	396.27%	-
Asia Pacific	509.17K	73.40K	3.19M	-
Asia Pacific Growth	593.74%	-97.70%	-	-
North America	110.51K	215.44K	50.00K	337.50K
North America Growth	-48.71%	330.87%	-85.19%	-
South America	1.48M	1.65M	-	-
South America Growth	-10.68%	-	-	-
Other Regions	472.38K	111.05K	-	-
Other Regions Growth	325.38%	-	-	-
Total	8.19M	6.71M	23.54M	4.43M
Total Growth	21.95%	-71.49%	431.67%	-

Source: S&P Global Market Intelligence.